Agustín Toll
Grup de recerca
- Melanoma: imatge, genètica i immunologia Accredited researcher (R3A)
Publicacions destacades
-
PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases
Autors:Referència: American Journal Of Dermatopathology 2018. -
The Polycomb proteins RING1B and EZH2 repress the tumoral pro-inflammatory function in metastasizing primary cutaneous squamous cell carcinoma
Autors:Referència: Carcinogenesis 2018. -
Targeting metastasis-initiating cells through the fatty acid receptor CD36.
Autors:Referència: Nature 2017. -
MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression
Autors:Referència: Molecular Cancer 2016. -
Identification of somatic gene mutations in penile squamous cell carcinoma
Autors:Referència: Genes Chromosomes & Cancer 2015. -
Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis.
Autors:Referència: Oncotarget 2015. -
Epithelial-to-mesenchymal transition in penile squamous cell carcinoma
Autors:Referència: Journal Of Urology 2015. -
Human beta papillomavirus DNA study in primary cutaneous squamous cell carcinomas and their corresponding metastases
Autors:Referència: Archives Of Dermatological Research 2014. -
mTOR Signaling Pathway in Penile Squamous Cell Carcinoma: pmTOR and peIF4E Over Expression Correlate with Aggressive Tumor Behavior
Autors:Referència: Journal Of Urology 2013. -
Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases
Autors:Referència: Journal Of Dermatological Science 2013.
Projectes destacats
-
Development and Validation of a Gene Expression assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma
Finançador: Castle BiosciencesDurada: 31/08/2021 - 23/03/2022 -
Estudio de fase 2 de REGN2810, un anticuerpo monoclonal totalmente humano contra la proteína de muerte celular programada-1 (PD-1), en pacientes con carcinoma epidermoide cutáneo avanzado
Finançador: Regeneron PharmaceuticalsDurada: 05/11/2019 -
Red de cáncer cutáneo no melanoma en Cataluña
Investigador/a principal: Agustín Toll, Agustín Toll AbellóFinançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer; Roche Farma, S.A.; Sun Pharmaceuticals Industries (Participante)Durada: 13/03/2019 -
Regulación epigenética de la función inflamatoria del componente epitelial en la progresión metastática del carcinoma escamoso cutáneo (CEC)
Investigador/a principal: María Inmaculada Hernández MuñozFinançador: INSTITUTO MUNICIPAL DE INVESTIGACION MEDICA (Sede o evento); Instituto de Salud Carlos IIIDurada: 01/01/2016 - 31/12/2018 -
Estudio del perfil genómico y de expresión en carcinomas escamosos cutáneos invasivos e intraepiteliales
Investigador/a principal: Agustin Toll AbelloFinançador: INSTITUTO MUNICIPAL DE INVESTIGACION MEDICA (Sede o evento)Durada: 01/01/2011 - 31/12/2013